| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Endocrinology and Metabolism (D.J.G.,), Bone Marrow Transplantation and Cancer Immunobiology Laboratory (L.W., I.R., S.S.), Hebrew University-Hadassah Medical Center, Jerusalem 91120, Israel; the Oxford Diabetes Research Laboratories, Radcliffe Infirmary (J.v.d.B., A.C.), Oxford, United Kingdom OX2 6HE; and the Department of Biochemistry, Tohoku University School of Medicine (H.O.), Sendai 9877, Japan
Address all correspondence and requests for reprints to: David J. Gross, M.D., Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem 91120, Israel. E-mail: gross{at}vms.huji.ac.il
Oral linomide, (quinoline-3-carboxamide), has been shown to prevent autoimmune insulitis, islet destruction, and diabetes in NOD mice treated at an early stage of the disease, but confers only partial protection in animals with advanced disease. Reg protein, the gene product of a complementary DNA isolated from a regenerating rat islet library, has been previously shown to induce expansion of ß-cell mass in pancreatectomized rats. To determine the effect of treatment combining immunomodulation and Reg protein on advanced autoimmune diabetes, we treated female NOD mice with oral linomide and ip Reg protein injections. In 14-week-old animals with less severe disease (glucose tolerant), treatment with each agent alone resulted in amelioration of diabetes, as did treatment with Reg alone in 5-week-old prediabetic mice. In 14-week-old animals with more severe disease (glucose intolerant), only treatment with the combination of both agents, but not that with each separately, resulted in amelioration of diabetes. Our study suggests that treatment aimed at abrogation of autoimmunity combined with expansion of ß-cell mass constitutes a potential therapeutic approach for treatment of insulin-dependent diabetes mellitus.
This article has been cited by other articles:
![]() |
W. Gurr, M. Shaw, Y. Li, and R. Sherwin RegII Is a {beta}-Cell Protein and Autoantigen in Diabetes of NOD Mice Diabetes, January 1, 2007; 56(1): 34 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, A. Ponton, H. Okamoto, S. Takasawa, P. L. Herrera, and J.-L. Liu Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E50 - E58. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiu, E. O. List, and J. J. Kopchick Differentially Expressed Proteins in the Pancreas of Diet-induced Diabetic Mice Mol. Cell. Proteomics, September 1, 2005; 4(9): 1311 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-H. Yuan, Y.-M. Jeng, H.-L. Chen, F.-J. Hsieh, C.-Y. Yang, P.-H. Lee, and H.-C. Hsu Opposite Roles of Human Pancreatitis-Associated Protein and REG1A Expression in Hepatocellular Carcinoma: Association of Pancreatitis-Associated Protein Expression with Low-Stage Hepatocellular Carcinoma, {beta}-Catenin Mutation, and Favorable Prognosis Clin. Cancer Res., April 1, 2005; 11(7): 2568 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okamoto and S. Takasawa Recent Advances in the Okamoto Model: The CD38-Cyclic ADP-Ribose Signal System and the Regenerating Gene Protein (Reg)-Reg Receptor System in {beta}-Cells Diabetes, December 1, 2002; 51(90003): S462 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Unno, K. Nata, N. Noguchi, Y. Narushima, T. Akiyama, T. Ikeda, K. Nakagawa, S. Takasawa, and H. Okamoto Production and Characterization of Reg Knockout Mice: Reduced Proliferation of Pancreatic {beta}-Cells in Reg Knockout Mice Diabetes, December 1, 2002; 51(90003): S478 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, M. Seno, H. Yamada, and I. Kojima Promotion of {beta}-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats Endocrinology, December 1, 2001; 142(12): 5379 - 5385. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akiyama, S. Takasawa, K. Nata, S. Kobayashi, M. Abe, N. J. Shervani, T. Ikeda, K. Nakagawa, M. Unno, S. Matsuno, et al. Activation of Reg gene, a gene for insulin-producing beta -cell regeneration: Poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation PNAS, December 22, 2000; (2000) 240458597. [Abstract] [Full Text] |
||||
![]() |
J. H. Noseworthy, J. S. Wolinsky, F. D. Lublin, J. N. Whitaker, A. Linde, P. Gjorstrup, and H. C. Sullivan Linomide in relapsing and secondary progressive MS: Part I: Trial design and clinical results Neurology, May 9, 2000; 54(9): 1726 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, T. Akiyama, K. Nata, M. Abe, M. Tajima, N. J. Shervani, M. Unno, S. Matsuno, H. Sasaki, S. Takasawa, et al. Identification of a Receptor for Reg (Regenerating Gene) Protein, a Pancreatic beta -Cell Regeneration Factor J. Biol. Chem., April 6, 2000; 275(15): 10723 - 10726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Graf, M. Schiesser, G. A. Scheele, K. Marquardt, T. W. Frick, R. W. Ammann, and D. Bimmler A Family of 16-kDa Pancreatic Secretory Stress Proteins Form Highly Organized Fibrillar Structures upon Tryptic Activation J. Biol. Chem., June 8, 2001; 276(24): 21028 - 21038. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akiyama, S. Takasawa, K. Nata, S. Kobayashi, M. Abe, N. J. Shervani, T. Ikeda, K. Nakagawa, M. Unno, S. Matsuno, et al. Activation of Reg gene, a gene for insulin-producing beta -cell regeneration: Poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation PNAS, January 2, 2001; 98(1): 48 - 53. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |